- Home
- BCTX vs OST Comparison
BCTX vs OST Comparison
Compare BCTX & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- OST
- Stock Information
- Founded
- BCTX 2014
- OST 2010
- Country
- BCTX Canada
- OST China
- Employees
- BCTX N/A
- OST N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- OST Industrial Machinery/Components
- Sector
- BCTX Health Care
- OST Technology
- Exchange
- BCTX Nasdaq
- OST Nasdaq
- Market Cap
- BCTX 14.4M
- OST 15.7M
- IPO Year
- BCTX N/A
- OST 2022
- Fundamental
- Price
- BCTX $7.72
- OST $1.64
- Analyst Decision
- BCTX Strong Buy
- OST
- Analyst Count
- BCTX 1
- OST 0
- Target Price
- BCTX $40.00
- OST N/A
- AVG Volume (30 Days)
- BCTX 92.9K
- OST 195.4K
- Earning Date
- BCTX 10-28-2025
- OST 09-16-2025
- Dividend Yield
- BCTX N/A
- OST N/A
- EPS Growth
- BCTX N/A
- OST N/A
- EPS
- BCTX N/A
- OST N/A
- Revenue
- BCTX N/A
- OST $38,333,251.00
- Revenue This Year
- BCTX N/A
- OST N/A
- Revenue Next Year
- BCTX N/A
- OST N/A
- P/E Ratio
- BCTX N/A
- OST N/A
- Revenue Growth
- BCTX N/A
- OST 0.34
- 52 Week Low
- BCTX $6.00
- OST $1.35
- 52 Week High
- BCTX $294.00
- OST $235.00
- Technical
- Relative Strength Index (RSI)
- BCTX 40.75
- OST 26.65
- Support Level
- BCTX $7.28
- OST $1.50
- Resistance Level
- BCTX $8.82
- OST $2.07
- Average True Range (ATR)
- BCTX 0.74
- OST 0.25
- MACD
- BCTX 0.58
- OST 1.59
- Stochastic Oscillator
- BCTX 60.82
- OST 12.84
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.